Synthetic intelligence biotech firm BenevolentAI is reorganizing its operations for the second time in lower than two years, and this time it says the modifications will return the corporate to its authentic mission of serving companions within the biopharmaceutical trade. Going ahead, London-based BenevolentAI will refocus its efforts on its core drug discovery and growth applied sciences. Wednesday's announcement supplied […]
